Antibiotic Resistance and Coping Strategies of Methicillin-Resistant Staphylococcus Species

Dear Colleagues,

Bacterial resistance to antimicrobial agents is currently one of the most emerging global public health problems, leading to treatment failures in many patient groups. Staphylococcus aureus and other Staphylococcus species are significant etiological factors of infection developing multiple mechanisms of antibiotic resistance, which are transferred rapidly between the strains in both hospital and community settings. The problem is particularly evident in the case of methicillin-resistant S. aureus (MRSA), which previously spread primarily in a hospital setting as hospital-acquired MRSA (HA-MRSA) but is nowadays increasingly found in community settings as community-acquired MRSA (CA-MRSA), displaying high infectivity and virulence. Prevention of methicillin-resistant Staphylococcus species transmitted in health care facilities is a major infection control challenge. Previous antibiotic treatments used are ineffective, so exploring alternative therapies is important.

In this Special Issue, we encourage research to clarify resistance mechanisms of Staphylococcus aureus. Papers about alternative therapies to solve the resistance of Staphylococcus aureus such as phages, new antimicrobial drugs and antimicrobial combinations will be welcomed.

Dr. Katarzyna Garbacz
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Staphylococcus aureus
• methicillin resistance
• MRSA
• multidrug resistance
• MDR
• alternative therapies